Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 135 articles:
HTML format
Text format



Single Articles


    October 2017
  1. IMURA S, Yamada S, Saito YU, Iwahashi S, et al
    miR-223 and Stathmin-1 Expression in Non-tumor Liver Tissue of Patients with Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:5877-5883.
    PubMed     Text format     Abstract available


  2. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Text format     Abstract available


  3. RATHMANN N, Kara K, Budjan J, Henzler T, et al
    Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Anticancer Res. 2017;37:5681-5685.
    PubMed     Text format     Abstract available


  4. IKEMOTO T, Shimada M, Ishikawa D, Kawashita Y, et al
    Peripheral Tr1 and Foxp3+ Treg as Markers of Recurrent Malignancies in Patients with Hepato-Biliary Pancreatic Cancers.
    Anticancer Res. 2017;37:5541-5552.
    PubMed     Text format     Abstract available


    September 2017
  5. SAKABE T, Azumi J, Umekita Y, Toriguchi K, et al
    Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:4881-4888.
    PubMed     Text format     Abstract available


  6. BI YE, Zhou Y, Wang M, Li L, et al
    Targeted Delivery of Cordycepin to Liver Cancer Cells Using Transferrin-conjugated Liposomes.
    Anticancer Res. 2017;37:5207-5214.
    PubMed     Text format     Abstract available


  7. CICERO G, Lo Re G, DE Luca R, Vernuccio F, et al
    Role of Densitometric Criteria in Evaluation of Effectiveness of Antiangiogenic Therapies in Metastatic Colorectal Cancer: An Italian Clinical Experience.
    Anticancer Res. 2017;37:5187-5192.
    PubMed     Text format     Abstract available


  8. DIVELLA R, Daniele A, DE Luca R, Simone M, et al
    Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:4867-4871.
    PubMed     Text format     Abstract available


    August 2017
  9. WANG L, Liu M, Liu L, Zheng Y, et al
    MR-guided Percutaneous Biopsy of Focal Hepatic Dome Lesions with Free-hand Combined with MR Fluoroscopy Using 1.0-T Open High-field Scanner.
    Anticancer Res. 2017;37:4635-4641.
    PubMed     Text format     Abstract available


  10. GONG Z, Chi C, Huang X, Chu H, et al
    Cyclophilin A Is Overexpressed in Hepatocellular Carcinoma and Is Associated with the Cell Cycle.
    Anticancer Res. 2017;37:4443-4447.
    PubMed     Text format     Abstract available


  11. ZHANG WG, Yin XC, Liu XF, Meng KW, et al
    Puerarin Induces Hepatocellular Carcinoma Cell Apoptosis Modulated by MAPK Signaling Pathways in a Dose-dependent Manner.
    Anticancer Res. 2017;37:4425-4431.
    PubMed     Text format     Abstract available


    July 2017
  12. HARADA N, Yoshizumi T, Yamashita YI, Soejima Y, et al
    Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.
    Anticancer Res. 2017;37:3763-3769.
    PubMed     Text format     Abstract available


  13. KRAUTBAUER S, Weiss TS, Wiest R, Schacherer D, et al
    Diagnostic Value of Systemic Cholesteryl Ester/Free Cholesterol Ratio in Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3527-3535.
    PubMed     Text format     Abstract available


  14. HAYASHI T, Yamashita T, Okada H, Oishi N, et al
    A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3397-3403.
    PubMed     Text format     Abstract available


  15. ISHII F, Yoshida Y, Yamauchi Y, Aisu N, et al
    Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated alphabeta T-cells.
    Anticancer Res. 2017;37:3933-3939.
    PubMed     Text format     Abstract available


  16. SHIBA I, Kouzaki R, Yamada H, Endo Y, et al
    Design and Synthesis of Novel Anti-metastatic Hypoxic Cytotoxin TX-2137 Targeting AKT Kinase.
    Anticancer Res. 2017;37:3877-3883.
    PubMed     Text format     Abstract available


  17. SETO K, Sakabe T, Itaba N, Azumi J, et al
    A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Anticancer Res. 2017;37:3569-3579.
    PubMed     Text format     Abstract available


  18. NAKAMURA M, Suetsugu A, Hasegawa K, Matsumoto T, et al
    Choline-Deficient-Diet-Induced Fatty Liver Is a Metastasis-Resistant Microenvironment.
    Anticancer Res. 2017;37:3429-3434.
    PubMed     Text format     Abstract available


    June 2017
  19. WAKIYAMA S, Matsumoto M, Haruki K, Gocho T, et al
    Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3207-3213.
    PubMed     Text format     Abstract available


  20. MATSUMOTO T, Ichikawa H, Imai J, Hayashi T, et al
    Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3183-3187.
    PubMed     Text format     Abstract available


  21. LIN CL, Chien RN, Liang KH, Ke PY, et al
    Intrahepatic HCV RNA Level and Genotype 1 Independently Associate with Hepatic Reticulon 3 Expression.
    Anticancer Res. 2017;37:2885-2891.
    PubMed     Text format     Abstract available


    May 2017
  22. MIYATA T, Yamashita YI, Yamao T, Umezaki N, et al
    Clinical Benefits of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: A Retrospective Single-institution Study.
    Anticancer Res. 2017;37:2673-2677.
    PubMed     Text format     Abstract available


  23. HASHIMOTO M, Kobayashi T, Ishiyama K, Ide K, et al
    Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy.
    Anticancer Res. 2017;37:2625-2631.
    PubMed     Text format     Abstract available


  24. LU LC, Chen PJ, Yeh YC, Hsu CH, et al
    Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study.
    Anticancer Res. 2017;37:2593-2599.
    PubMed     Text format     Abstract available


  25. KANAJI N, Kita N, Kadowaki N, Bandoh S, et al
    Fibronectin and Hepatocyte Growth Factor Produced by Lung Fibroblasts Augment Migration and Invasion of Malignant Pleural Mesothelioma Cells.
    Anticancer Res. 2017;37:2393-2400.
    PubMed     Text format     Abstract available


  26. BARABINO M, Gatti A, Santambrogio R, Polizzi M, et al
    Intraoperative Local Ablative Therapies Combined with Surgery for the Treatment of Bilobar Colorectal Liver Metastases.
    Anticancer Res. 2017;37:2743-2750.
    PubMed     Text format     Abstract available


    April 2017
  27. MALKI A, El-Sharkawy A, El Syaed M, Bergmeier S, et al
    Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.
    Anticancer Res. 2017;37:1591-1601.
    PubMed     Text format     Abstract available


  28. TAHARA T, Tahara S, Horiguchi N, Kawamura T, et al
    Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.
    Anticancer Res. 2017;37:1997-2001.
    PubMed     Text format     Abstract available


  29. OTTAIANO A, Capozzi M, DE Divitiis C, VON Arx C, et al
    Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.
    Anticancer Res. 2017;37:1975-1978.
    PubMed     Text format     Abstract available


  30. HARADA N, Yoshizumi T, Maeda T, Kayashima H, et al
    Preoperative Pancreatic Stiffness by Real-time Tissue Elastography to Predict Pancreatic Fistula After Pancreaticoduodenectomy.
    Anticancer Res. 2017;37:1909-1915.
    PubMed     Text format     Abstract available


    March 2017
  31. DE PASQUALE MD, de Ville de Goyet J, Monti L, Grimaldi C, et al
    Bevacizumab Combined with Chemotherapy in Children Affected by Hepatocellular Carcinoma: a Single-center Experience.
    Anticancer Res. 2017;37:1489-1493.
    PubMed     Text format     Abstract available


  32. ITOH S, Uchiyama H, Ikeda Y, Morita K, et al
    Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.
    Anticancer Res. 2017;37:1381-1385.
    PubMed     Text format     Abstract available


  33. MARQUES LA, Semprebon SC, Sartori D, DE Fatima A, et al
    Comparison of the Effects of Monastrol and Oxomonastrol on Human Hepatoma Cell Line HepG2/C3A.
    Anticancer Res. 2017;37:1197-1204.
    PubMed     Text format     Abstract available


  34. YOSHIKAWA M, Morine Y, Ikemoto T, Imura S, et al
    Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.
    Anticancer Res. 2017;37:1169-1175.
    PubMed     Text format     Abstract available


  35. KOMATSU H, Masuda T, Iguchi T, Nambara S, et al
    Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:1083-1090.
    PubMed     Text format     Abstract available


  36. TRESKA V, Fichtl J, Bruha J, Liska V, et al
    Liver Resections for Colorectal Metastases in Patients Aged Over 75 Years.
    Anticancer Res. 2017;37:1529-1533.
    PubMed     Text format     Abstract available


  37. D'ONOFRIO M, Cingarlini S, Ortolani S, Crosara S, et al
    Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.
    Anticancer Res. 2017;37:1305-1311.
    PubMed     Text format     Abstract available


    February 2017
  38. IKEGAMI T, Yoshizumi T, Kawasaki J, Nagatsu A, et al
    Surgical Resection for Lymph Node Metastasis After Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:891-895.
    PubMed     Text format     Abstract available


  39. FRIEDMAN P, Lai JP
    Liver Metastasis of Urothelial Carcinoma with Hepatoid Features: An Unusual Morphological Finding.
    Anticancer Res. 2017;37:801-804.
    PubMed     Text format     Abstract available


  40. CHEN YL, Huang WC, Yao HL, Chen PM, et al
    Down-regulation of RASA1 Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:781-785.
    PubMed     Text format     Abstract available


  41. ZENG H, Wu HC, Wang Q, Yang HI, et al
    Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
    Anticancer Res. 2017;37:637-644.
    PubMed     Text format     Abstract available


  42. ZHANG S, Tang D, Zang W, Yin G, et al
    Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:465-473.
    PubMed     Text format     Abstract available


  43. MAGISTRI P, Tarantino G, Ballarin R, Berretta M, et al
    The Evolving Role of Local Treatments for HCC in the Third Millennium.
    Anticancer Res. 2017;37:389-401.
    PubMed     Text format     Abstract available


  44. RYU SH, Heo SH, Park EY, Choi KC, et al
    Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes.
    Anticancer Res. 2017;37:607-614.
    PubMed     Text format     Abstract available


    January 2017

  45. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. General and Surgical Pathology. Volumes 1, 2, 3, 4.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    



  46. Hepatocellular Carcinoma. Diagnosis and Treatment. Third Edition.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    


  47. SONOHARA F, Inokawa Y, Kanda M, Nishikawa Y, et al
    Association of Inflammasome Components in Background Liver with Poor Prognosis After Curatively-resected Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:293-300.
    PubMed     Text format     Abstract available


  48. CHIANG IT, Chen WT, Tseng CW, Chen YC, et al
    Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.
    Anticancer Res. 2017;37:161-167.
    PubMed     Text format     Abstract available


  49. NASS N, Streit S, Wybranski C, Jurgens J, et al
    Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Anticancer Res. 2017;37:87-93.
    PubMed     Text format     Abstract available


  50. FUJIYOSHI K, Yamamoto G, Takenoya T, Takahashi A, et al
    Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Anticancer Res. 2017;37:239-247.
    PubMed     Text format     Abstract available


  51. RADES D, Bolm L, Schild SE, Bartscht T, et al
    Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer.
    Anticancer Res. 2017;37:203-206.
    PubMed     Text format     Abstract available


  52. MORIS D, Dimitroulis D, Vernadakis S, Papalampros A, et al
    Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.
    Anticancer Res. 2017;37:9-14.
    PubMed     Text format     Abstract available


    December 2016
  53. YAMASHITA YI, Wang H, Kurihara T, Tsujita E, et al
    Clinical Significances of Preoperative Classification of Intrahepatic Cholangiocarcinoma: Different Characteristics of Perihilar vs. Peripheral ICC.
    Anticancer Res. 2016;36:6563-6569.
    PubMed     Text format     Abstract available


  54. MA X, Wang X, Yang C, Wang Z, et al
    DANCR Acts as a Diagnostic Biomarker and Promotes Tumor Growth and Metastasis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:6389-6398.
    PubMed     Text format     Abstract available


  55. TANG M, Etokidem E, Lai K
    The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:6265-6271.
    PubMed     Text format     Abstract available


    November 2016
  56. GIORGIO A, Merola MG, Montesarchio L, Merola F, et al
    Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial.
    Anticancer Res. 2016;36:6179-6183.
    PubMed     Text format     Abstract available


  57. GARNIER A, Ilmer M, Kappler R, Berger M, et al
    Therapeutic Innovations for Targeting Hepatoblastoma.
    Anticancer Res. 2016;36:5577-5592.
    PubMed     Text format     Abstract available


  58. TAK E, Hwang S, Lee HC, Ko GY, et al
    Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue.
    Anticancer Res. 2016;36:6059-6069.
    PubMed     Text format     Abstract available


    October 2016
  59. HARIMOTO N, Yoshizumi T, Shimagaki T, Nagatsu A, et al
    Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5537-5542.
    PubMed     Text format     Abstract available


  60. KORNBERG A, Witt U, Kornberg J, Ceyhan GO, et al
    Prognostic Impact of Intraoperative Blood Loss in Liver Transplant Patients with Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5355-5364.
    PubMed     Text format     Abstract available


  61. SHEN J, Yeh CC, Wang Q, Gurvich I, et al
    Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.
    Anticancer Res. 2016;36:5307-5314.
    PubMed     Text format     Abstract available


  62. HIWATASHI K, Ueno S, Sakoda M, Iino S, et al
    Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5183-5188.
    PubMed     Text format     Abstract available


  63. HASS HG, Vogel U, Scheurlen M, Jobst J, et al
    Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5087-5095.
    PubMed     Text format     Abstract available


  64. CHANG CD, Lin PY, Hsu JL, Shih WL, et al
    Ursolic Acid Suppresses Hepatitis B Virus X Protein-mediated Autophagy and Chemotherapeutic Drug Resistance.
    Anticancer Res. 2016;36:5097-5107.
    PubMed     Text format     Abstract available


  65. ALT M, Truant S, Renaud-Vantroys T, Sequier C, et al
    Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study.
    Anticancer Res. 2016;36:5551-5555.
    PubMed     Text format     Abstract available


    September 2016
  66. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Hepatic Resection After Prehepatectomy Chemotherapy for Metastatic Colorectal Cancer: A Propensity-Matched Analysis.
    Anticancer Res. 2016;36:4725-30.
    PubMed     Text format     Abstract available


  67. INOKAWA Y, Sonohara F, Kanda M, Hayashi M, et al
    Correlation Between Poor Prognosis and Lower TPPP Gene Expression in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:4639-45.
    PubMed     Text format     Abstract available


  68. NISHIMURA M, Murayama Y, Harada K, Kamada Y, et al
    Photodynamic Diagnosis of Hepatocellular Carcinoma Using 5-Aminolevulinic Acid.
    Anticancer Res. 2016;36:4569-74.
    PubMed     Text format     Abstract available


  69. KOGAME M, Nagai H, Shinohara M, Igarashi Y, et al
    Th2 Dominance Might Induce Carcinogenesis in Patients with HCV-related Liver Cirrhosis.
    Anticancer Res. 2016;36:4529-36.
    PubMed     Text format     Abstract available


  70. PIKOULIS E, Margonis GA, Andreatos N, Sasaki K, et al
    Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:4805-11.
    PubMed     Text format     Abstract available


  71. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Parenchymal Congestion Is Important for Rapid Regeneration of the Future Liver Remnant Following the ALPPS Procedure.
    Anticancer Res. 2016;36:4731-8.
    PubMed     Text format     Abstract available


    August 2016
  72. BUDJAN J, Sauter EA, Morelli JN, Nolden M, et al
    Semi-automatic Volumetric Measurement of Treatment Response in Hepatocellular Carcinoma After Trans-arterial Chemoembolization.
    Anticancer Res. 2016;36:4353-8.
    PubMed     Text format     Abstract available


  73. ITOH S, Kohnoe S, Shirabe K, Yoshida D, et al
    Validity of Hepatic or Pancreatic Resection for Elderly Patients Aged 85 Years or Older at a Single Community Hospital in Japan.
    Anticancer Res. 2016;36:4289-92.
    PubMed     Text format     Abstract available


  74. YEH CN, Wang SY, Chen YY, Chen MH, et al
    A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2016;36:4249-58.
    PubMed     Text format     Abstract available


  75. NANASHIMA A, Izumino H, Sumida Y, Tominaga T, et al
    Relationship Between Urinary 8-hydroxydeoxyguanine (8-OHdG) Levels and Clinicopathological Findings in Hepatobiliary Malignancies.
    Anticancer Res. 2016;36:3899-903.
    PubMed     Text format     Abstract available


  76. DJAAFAR S, Dunand-Sautier I, Gonelle-Gispert C, Lacotte S, et al
    Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-gamma-inducible Chemokines.
    Anticancer Res. 2016;36:4019-32.
    PubMed     Text format     Abstract available


    July 2016
  77. ETO D, Hisaka T, Horiuchi H, Uchida S, et al
    Expression of HSP27 in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3775-9.
    PubMed     Text format     Abstract available


  78. HONDA T, Inagawa H
    Gene Expression in Lipopolysaccharide-treated Human Monocytes Following Interaction with Hepatic Cancer Cells.
    Anticancer Res. 2016;36:3699-704.
    PubMed     Text format     Abstract available


  79. DINH VY, Bhatia S, Narayanan G, Yrizarry J, et al
    Pilot Study of Intrahepatic Artery Chemotherapy in Combination with Sorafenib in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3555-63.
    PubMed     Text format     Abstract available


  80. HATOOKA M, Kawaoka T, Aikata H, Morio K, et al
    Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
    Anticancer Res. 2016;36:3523-9.
    PubMed     Text format     Abstract available


  81. ALIBERTI C, Carandina R, Sarti D, Mulazzani L, et al
    Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
    Anticancer Res. 2016;36:3515-21.
    PubMed     Text format     Abstract available


  82. SHAH BK, Kandel P, Khanal A
    Second Primary Malignancies in Hepatocellular Cancer - A US Population-based Study.
    Anticancer Res. 2016;36:3511-4.
    PubMed     Text format     Abstract available


  83. HARADA N, Maeda T, Yoshizumi T, Ikeda T, et al
    Laparoscopic Liver Resection Is a Feasible Treatment for Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Anticancer Res. 2016;36:3489-97.
    PubMed     Text format     Abstract available


  84. AKINWANDE O, Scoggins C, Martin RC
    Early Experience with 70-150 mum Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Anticancer Res. 2016;36:3413-8.
    PubMed     Text format     Abstract available


  85. SAKAMOTO T, Ishii Y, Shiba H, Furukawa K, et al
    Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production.
    Anticancer Res. 2016;36:3301-6.
    PubMed     Text format     Abstract available


  86. ELLERKAMP V, Bortel N, Schmid E, Kirchner B, et al
    Photodynamic Therapy Potentiates the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells.
    Anticancer Res. 2016;36:3363-72.
    PubMed     Text format     Abstract available


  87. PASCALE F, Ghegediban SH, Bedouet L, Namur J, et al
    bFGF Up-regulation Reduces Spontaneous Necrosis of VX2 Tumors Without Increasing Tumoral Microvascular Density.
    Anticancer Res. 2016;36:3315-20.
    PubMed     Text format     Abstract available


  88. MATSUI T, Nagata N, Hirata K, Okazaki S, et al
    Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX Trial.
    Anticancer Res. 2016;36:3437-43.
    PubMed     Text format     Abstract available


    June 2016
  89. OKADA K, Kawai M, Ueno M, Hirono S, et al
    Depth of Hepatic Infiltration and Lymph Node Swelling as Factors for Considering Surgery for T2-4 Gallbladder Carcinoma Patients.
    Anticancer Res. 2016;36:3075-80.
    PubMed     Text format     Abstract available


  90. ITOH S, Yoshizumi T, Kimura K, Okabe H, et al
    Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3029-34.
    PubMed     Text format     Abstract available


  91. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Hepatic Resection for Liver Metastases from Cervical Cancer Is Safe and May Have Survival Benefit.
    Anticancer Res. 2016;36:3023-7.
    PubMed     Text format     Abstract available


  92. CHEN YL, Chen PM, Lin PY, Hsiau YT, et al
    ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients.
    Anticancer Res. 2016;36:2983-8.
    PubMed     Text format     Abstract available


  93. KOMATSU H, Iguchi T, Masuda T, Ueda M, et al
    HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2767-73.
    PubMed     Text format     Abstract available


  94. YANG H, Ding R, Tong Z, Huang J, et al
    siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2675-82.
    PubMed     Text format     Abstract available


  95. BRADATSCH A, Kornprat P, Bacher H, Cerwenka H, et al
    The Value of Lymph Node Dissection in the Surgery of Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:2993-7.
    PubMed     Text format     Abstract available


  96. RATHMANN N, Budjan J, Mari F, Grimm R, et al
    Semiautomatic Whole-lesion Apparent Diffusion Coefficient Assessment for Early Prediction of Liver Tumor Response to Radioembolization.
    Anticancer Res. 2016;36:2961-6.
    PubMed     Text format     Abstract available


  97. SEMAAN A, Branchi V, Marowsky AL, VON Websky M, et al
    Incidentally Detected Focal Liver Lesions - A Common Clinical Management Dilemma Revisited.
    Anticancer Res. 2016;36:2923-32.
    PubMed     Text format     Abstract available


    May 2016
  98. IGUCHI T, Komatsu H, Masuda T, Nambara S, et al
    Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2139-44.
    PubMed     Text format     Abstract available


  99. KIM CW, Roh SA, Tak KH, Koh BM, et al
    ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor.
    Anticancer Res. 2016;36:2397-406.
    PubMed     Text format     Abstract available


  100. YAMAUCHI K, Kokuryo T, Yokoyama Y, Uehara K, et al
    Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
    Anticancer Res. 2016;36:2175-9.
    PubMed     Text format     Abstract available


  101. TRESKA V
    Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives.
    Anticancer Res. 2016;36:2065-71.
    PubMed     Text format     Abstract available


    April 2016
  102. NITTA H, Baba H, Sugimori K, Furuse J, et al
    Chemotherapy-induced Nausea and Vomiting in Patients with Hepatobiliary and Pancreatic Cancer Treated with Chemotherapy: A Prospective Observational Study by the CINV Study Group of Japan.
    Anticancer Res. 2016;36:1929-35.
    PubMed     Text format     Abstract available


  103. HIROSHIMA Y, Matsuo K, Kawaguchi D, Kikuchi Y, et al
    Modified Liver Hanging Maneuver for En-bloc Right-sided Hepatectomy Combined with Total Caudate Lobectomy for Colon-Cancer Liver Metastasis and Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:1729-35.
    PubMed     Text format     Abstract available


  104. UMEHARA M, Umehara Y, Takahashi K, Murata A, et al
    Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
    Anticancer Res. 2016;36:1949-54.
    PubMed     Text format     Abstract available


  105. FICHTL J, Treska V, Lysak D, Mirka H, et al
    Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.
    Anticancer Res. 2016;36:1901-7.
    PubMed     Text format     Abstract available


  106. KAIBORI M, Matsui K, Ishizaki M, Iida H, et al
    Intraoperative Detection of Superficial Liver Tumors by Fluorescence Imaging Using Indocyanine Green and 5-aminolevulinic Acid.
    Anticancer Res. 2016;36:1841-9.
    PubMed     Text format     Abstract available


  107. BACALBASA N, Taras C, Orban C, Iliescu L, et al
    Atypical Right Hepatectomy for Liver Metastasis from Ovarian Leiomyosarcoma - A Case Report and Literature Review.
    Anticancer Res. 2016;36:1835-40.
    PubMed     Text format     Abstract available


  108. NISMAN B, Appelbaum L, Yutkin V, Nechushtan H, et al
    Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and Liver.
    Anticancer Res. 2016;36:1791-7.
    PubMed     Text format     Abstract available


  109. MATSUMOTO T, Suetsugu A, Hasegawa K, Nakamura M, et al
    Color-Coded Imaging of Syngeneic Orthotopic Malignant Lymphoma Interacting with Host Stromal Cells During Metastasis.
    Anticancer Res. 2016;36:1473-8.
    PubMed     Text format     Abstract available


    March 2016
  110. WANG LG, Jiang WJ, Fan WJ, Zheng YB, et al
    Microwave Ablation: The Differences Between Biliary Cirrhosis and Normal Porcine Liver Using a Cooled-tip Electrode.
    Anticancer Res. 2016;36:1221-6.
    PubMed     Text format     Abstract available


    February 2016
  111. KIMURA K, Itoh S, Kurihara T, Yoshida Y, et al
    Predictors of Benign Status in Liver Tumors Under 3 cm in Diameter Misdiagnosed as Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:793-7.
    PubMed     Text format     Abstract available


  112. BARA T JR, Gurzu S, Jung I, Muresan M, et al
    Giant Cavernous Hepatic Hemangioma Diagnosed Incidentally in a Perimenopausal Obese Female with Endometrial Adenocarcinoma: A Case Report.
    Anticancer Res. 2016;36:769-72.
    PubMed     Text format     Abstract available


  113. WUBETU GY, Morine Y, Teraoku H, Yoshikawa M, et al
    High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Anticancer Res. 2016;36:757-62.
    PubMed     Text format     Abstract available


  114. DAVAADORJ M, Imura S, Saito YU, Morine Y, et al
    Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:659-64.
    PubMed     Text format     Abstract available


  115. MIYAMOTO Y, Sakamoto Y, Ohuchi M, Tokunaga R, et al
    Orbital Apex Syndrome Caused by Invasive Aspergillosis as an Adverse Effect of Systemic Chemotherapy for Metastatic Colorectal Cancer: a Case Report.
    Anticancer Res. 2016;36:821-3.
    PubMed     Text format     Abstract available


  116. KUCERA R, Topolcan O, Fiala O, Kinkorova J, et al
    The Role of TPS and TPA in the Diagnostics of Distant Metastases.
    Anticancer Res. 2016;36:773-7.
    PubMed     Text format     Abstract available


    January 2016
  117. YOSHIZUMI T, Harimoto N, Itoh S, Okabe H, et al
    Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era.
    Anticancer Res. 2016;36:439-45.
    PubMed     Text format     Abstract available


  118. UCHIYAMA H, Minagawa R, Itoh S, Kajiyama K, et al
    Favorable Outcomes of Hepatectomy for Ruptured Hepatocellular Carcinoma: Retrospective Analysis of Primary R0-Hepatectomized Patients.
    Anticancer Res. 2016;36:379-85.
    PubMed     Text format     Abstract available


  119. SHASTRI A, Msaouel P, Montagna C, White S, et al
    Primary Hepatic Small Cell Carcinoma: Two Case Reports, Molecular Characterization and Pooled Analysis of Known Clinical Data.
    Anticancer Res. 2016;36:271-7.
    PubMed     Text format     Abstract available


  120. AKINWANDE O, Philips P, Scoggins C, Martin RC, et al
    Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study.
    Anticancer Res. 2016;36:239-46.
    PubMed     Text format     Abstract available


  121. MASUDA GO, Yashiro M, Kitayama K, Miki Y, et al
    Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
    Anticancer Res. 2016;36:129-36.
    PubMed     Text format     Abstract available


    December 2015
  122. SHIRABE K, Sugimachi K, Harada N, Kayashima H, et al
    Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.
    Anticancer Res. 2015;35:6963-9.
    PubMed     Text format     Abstract available


  123. SATO S, Tanaka K, Nojiri K, Kumamoto T, et al
    Hepatic Resection for Hepatocellular Carcinoma in the Elderly: Selecting Hepatectomy Procedures Based on Patient Age.
    Anticancer Res. 2015;35:6855-60.
    PubMed     Text format     Abstract available


  124. IWASE Y, Nakayama M, Yamato M, Okano T, et al
    A Biomimicking Tumor Tissue Model Using Hepatocellular Carcinoma Cell Sheet in a Collagen Sandwich System.
    Anticancer Res. 2015;35:6481-6.
    PubMed     Text format     Abstract available


  125. ENOMOTO H, Nakamura H, Liu W, Iwata Y, et al
    Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
    Anticancer Res. 2015;35:6475-9.
    PubMed     Text format     Abstract available


  126. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases.
    Anticancer Res. 2015;35:6919-23.
    PubMed     Text format     Abstract available


  127. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Long-term Survivors After Liver Resection for Breast Cancer Liver Metastases.
    Anticancer Res. 2015;35:6913-7.
    PubMed     Text format     Abstract available


  128. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    The Role of Re-resection for Breast Cancer Liver Metastases-a Single Center Experience.
    Anticancer Res. 2015;35:6877-80.
    PubMed     Text format     Abstract available


    November 2015
  129. SUETSUGU A, Hiroshima Y, Matsumoto T, Hasagawa K, et al
    Recruitment of Cancer-Associated Fibroblasts and Blood Vessels by Orthotopic Liver Tumors Imaged in Red Fluorescent Protein (RFP) Transgenic Nude Mice.
    Anticancer Res. 2015;35:5821-5.
    PubMed     Text format     Abstract available


  130. ANDO K, Oki E, Saeki H, Kasagi Y, et al
    Number of Lymph Node Metastases May Indicate the Regimen for Adjuvant Chemotherapy in Patients with Stage III Colorectal Cancer.
    Anticancer Res. 2015;35:6207-11.
    PubMed     Text format     Abstract available


  131. MATSUMOTO H, Okumura H, Murakami H, Kubota H, et al
    Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer.
    Anticancer Res. 2015;35:6193-9.
    PubMed     Text format     Abstract available


  132. YAMADA M, Iihara H, Fujii H, Ishihara M, et al
    Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients.
    Anticancer Res. 2015;35:6175-81.
    PubMed     Text format     Abstract available


    October 2015
  133. URATANI R, Toiyama Y, Shimura T, Mori K, et al
    Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2015;35:5639-48.
    PubMed     Text format     Abstract available


  134. SASAKI Y, Osada S, Matsui S, Imai H, et al
    Preoperative Chemotherapy Can Change the Surgical Procedure for Hepatectomy in Patients with Liver Metastasis of Colorectal Cancer.
    Anticancer Res. 2015;35:5485-9.
    PubMed     Text format     Abstract available


  135. GIUSCA SE, Caruntu ID, Cimpean AM, Avadanei RE, et al
    Tryptase-positive and CD117 Positive Mast Cells Correlate with Survival in Patients with Liver Metastasis.
    Anticancer Res. 2015;35:5325-31.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: